TACE was performed with a 5 French RH catheter (Cook, Bloomington, Ind), a Cobra catheter (Cook), or a microcatheter (Progreat, Terumo, Tokyo, Japan) being inserted as carefully as possible through the lobar, segmental, or subsegmental arteries, depending on both the tumor location and the hepatic functional reserve of the patient. To start, an emulsion of 2–12 ml of Lipiodol (Lipiodol, Guerbet, Aulnay-Sous-Bois, France), 60–90 mg of cisplatin, and 20–40 mg of doxorubicin hydrochloride was injected into the feeding artery. The dosage of Lipiodol, cisplatin, and doxorubicin was based on tumor size and vascularity, the presence or absence of an arterioportal shunt, and underlying liver function. Once the emulsion injection was complete, gelatin sponge particles (300–500 µm) mixed with contrast medium were administered into the feeding arteries until stoppage of arterial flow was achieved.
5 french rh catheter
The 5 French RH catheter is a medical device designed for use in various clinical procedures. It is a single-lumen catheter with an outer diameter of 5 French, which is a common size used in diagnostic and interventional procedures. The catheter is intended to facilitate the introduction and manipulation of other medical devices within the body's vascular system.
Lab products found in correlation
2 protocols using 5 french rh catheter
Combined TACE and RFA for Liver Tumors
TACE was performed with a 5 French RH catheter (Cook, Bloomington, Ind), a Cobra catheter (Cook), or a microcatheter (Progreat, Terumo, Tokyo, Japan) being inserted as carefully as possible through the lobar, segmental, or subsegmental arteries, depending on both the tumor location and the hepatic functional reserve of the patient. To start, an emulsion of 2–12 ml of Lipiodol (Lipiodol, Guerbet, Aulnay-Sous-Bois, France), 60–90 mg of cisplatin, and 20–40 mg of doxorubicin hydrochloride was injected into the feeding artery. The dosage of Lipiodol, cisplatin, and doxorubicin was based on tumor size and vascularity, the presence or absence of an arterioportal shunt, and underlying liver function. Once the emulsion injection was complete, gelatin sponge particles (300–500 µm) mixed with contrast medium were administered into the feeding arteries until stoppage of arterial flow was achieved.
Trans-arterial Chemoembolization for Tumor Treatment
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!